DRUG

DRUG Financing Cash Flow

$277.00MTTM · CAD

Period ending:

DRUG FY Cash from FinancingCAD
DRUG FY Cash from Financing2019-09-30: $122.00K2020-09-30: $1.01M2021-09-30: $26.06M2022-09-30: $5.20M2023-09-30: $2.19M2024-09-30: $810.57K2025-09-30: $85.57M$85.57M$0.00
2019-09-302025-09-30

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in CAD. Dates are period ends; a fiscal year may differ from a calendar year.

DRUG financing cash flow history

Cash from issuing/repaying debt and equity. The available annual fiscal periods series contains 7 observations from Sep 30, 2019 to Sep 30, 2025.

Bright Minds Biosciences Inc Financing Cash Flow — Annual fiscal periods (CAD)
Period endingFinancing Cash Flow (CAD)
85,567,491
810,572
2,189,686
5,196,190
26,055,600
1,008,330
122,000

Compare financing cash flow

All DRUG financial metrics · DRUG stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.